LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 14

Search options

  1. Article ; Online: Hemodynamic Predictors of Stabilization When Using Temporary Mechanical Support for Cardiogenic Shock from Acute on Chronic Heart Failure.

    Wolfe, Jonathan D / Deych, Elena / Sintek, Marc A / Schilling, Joel D

    The American journal of cardiology

    2023  Volume 195, Page(s) 83–90

    Abstract: Cardiogenic shock from acute on chronic heart failure is a lethal condition that frequently requires temporary mechanical circulatory support devices (tMCS) as a bridge to stabilization, durable support, or heart transplantation. However, there are ... ...

    Abstract Cardiogenic shock from acute on chronic heart failure is a lethal condition that frequently requires temporary mechanical circulatory support devices (tMCS) as a bridge to stabilization, durable support, or heart transplantation. However, there are limited data on methods to optimize use of tMCS in this population. We identified patients who received tMCS devices for cardiogenic shock from acute on chronic heart failure at a single center from August 2016 to July 2020. All the patients had invasive hemodynamic data before and immediately after tMCS placement. We classified patients according to whether they showed stabilization or decompensation with tMCS. We then evaluated hemodynamics pre-tMCS, post-tMCS, and the change in hemodynamics with tMCS (∆-tMCS) and assessed their relationship with clinical outcomes. Among 111 patients who received tMCS, 71 stabilized, and 40 decompensated. Post-tMCS hemodynamics were more likely than were pre-tMCS or ∆-tMCS to predict stabilization. Post-tMCS cardiac index >2.1 (area under the curve: 92.2) and cardiac power index >0.3 (area under the curve: 89.6) were the best predictors of stabilization. Patients who decompensated had increased in-hospital all-cause mortality (hazard ratio 3.06 [1.29 to 7.24], p = 0.011), cardiovascular mortality, and increased hospital and intensive care unit length of stay and were less likely to receive left ventricular assist device or heart transplant (hazard ratio 0.56 [0.36 to 0.88], p = 0.01). In conclusion, among patients with cardiogenic shock from acute on chronic heart failure who received tMCS, post-tMCS cardiac index and cardiac power index were highly predictive of stabilization. Those who decompensated had increased mortality, hospital length of stay, and intensive care unit length of stay and were less likely to receive heart replacement therapy.
    MeSH term(s) Humans ; Shock, Cardiogenic/etiology ; Shock, Cardiogenic/therapy ; Heart Failure/complications ; Heart Failure/therapy ; Heart Transplantation ; Hospital Mortality ; Hemodynamics ; Heart-Assist Devices ; Treatment Outcome
    Language English
    Publishing date 2023-04-07
    Publishing country United States
    Document type Journal Article
    ZDB-ID 80014-4
    ISSN 1879-1913 ; 0002-9149
    ISSN (online) 1879-1913
    ISSN 0002-9149
    DOI 10.1016/j.amjcard.2023.02.029
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Acute right ventricular failure and pulseless electrical activity arrest following auto-transfusion of blood.

    Agboola, Kolade M / Lasala, John M / Sintek, Marc A / Noheria, Amit

    Journal of cardiology cases

    2018  Volume 17, Issue 4, Page(s) 119–122

    Abstract: Air embolism is a rare but potentially catastrophic complication of interventional procedures. The occurrence of acute right ventricular dysfunction during intraoperative auto-transfusion of blood, presumably related to pulmonary embolism of agitated air ...

    Abstract Air embolism is a rare but potentially catastrophic complication of interventional procedures. The occurrence of acute right ventricular dysfunction during intraoperative auto-transfusion of blood, presumably related to pulmonary embolism of agitated air microbubbles and microthrombi, is less commonly recognized. We report a case of auto-transfusion complicated by acute right ventricular failure and pulseless electrical activity arrest. Auto-transfusion of recovered blood is a practical solution to reduce need for post-procedure allogenic transfusions. Although such interventions are frequently performed without complications, they do have inherent risks that should be readily acknowledged. This case clearly describes a severe complication and sequelae of auto-transfusion. <
    Language English
    Publishing date 2018-01-12
    Publishing country Japan
    Document type Case Reports
    ISSN 1878-5409
    ISSN 1878-5409
    DOI 10.1016/j.jccase.2017.12.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Dynamic Evaluation of Coronary Anomalies Originating from the Opposite Sinus of Valsalva (ACAOS).

    Sintek, Marc A / Singh, Jasvindar / Billadello, Joseph J

    Current treatment options in cardiovascular medicine

    2015  Volume 17, Issue 11, Page(s) 47

    Abstract: Opinion statement: Coronary anomalies originating from the opposite sinus of Valsalva (ACAOS) are a rare anomaly associated with sudden cardiac death. Dynamic, invasive evaluation using coronary angiography, intravascular ultrasound, and fractional flow ...

    Abstract Opinion statement: Coronary anomalies originating from the opposite sinus of Valsalva (ACAOS) are a rare anomaly associated with sudden cardiac death. Dynamic, invasive evaluation using coronary angiography, intravascular ultrasound, and fractional flow reserve can more clearly identify important pathophysiologic variants and guide treatment. This dynamic evaluation can assist the clinician in the appropriate surgical and percutaneous treatment options and aid in patient counseling. Long-term outcomes data regarding treatment and prognosis is still lacking.
    Language English
    Publishing date 2015-09-05
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2057337-6
    ISSN 1534-3189 ; 1092-8464
    ISSN (online) 1534-3189
    ISSN 1092-8464
    DOI 10.1007/s11936-015-0407-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Patient evaluation and selection for transcatheter aortic valve replacement: the heart team approach.

    Sintek, Marc / Zajarias, Alan

    Progress in cardiovascular diseases

    2014  Volume 56, Issue 6, Page(s) 572–582

    Abstract: Transcatheter aortic valve replacement (TAVR) has been shown to significantly impact mortality and quality of life in patients with severe aortic stenosis (AS) who are deemed high risk for surgical aortic valve replacement (SAVR). Essential to these ... ...

    Abstract Transcatheter aortic valve replacement (TAVR) has been shown to significantly impact mortality and quality of life in patients with severe aortic stenosis (AS) who are deemed high risk for surgical aortic valve replacement (SAVR). Essential to these outcomes is proper patient selection. The multidisciplinary TAVR heart team was created to provide comprehensive patient evaluation and aid in proper selection. This review with outline the history and components of the heart team, and delineate the team's role in risk and frailty assessment, evaluation of common co-morbidities that impact outcomes, and the complex multi-modality imaging necessary for procedural planning and patient selection. The heart team is critical in determining patient eligibility and benefit and the optimal operative approach for TAVR. The future of structural heart disease will certainly require a team approach, and the TAVR heart team will serve as the successful model.
    MeSH term(s) Aortic Valve Stenosis/diagnosis ; Aortic Valve Stenosis/therapy ; Cardiac Catheterization/adverse effects ; Decision Support Techniques ; Heart Valve Prosthesis Implantation/adverse effects ; Heart Valve Prosthesis Implantation/methods ; Humans ; Multimodal Imaging/methods ; Patient Care Team ; Patient Selection ; Predictive Value of Tests ; Risk Factors ; Treatment Outcome
    Language English
    Publishing date 2014-05
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 209312-1
    ISSN 1873-1740 ; 1532-8643 ; 0033-0620
    ISSN (online) 1873-1740 ; 1532-8643
    ISSN 0033-0620
    DOI 10.1016/j.pcad.2014.02.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Excimer Laser Coronary Angioplasty in Coronary Lesions: Use and Safety From the NCDR/CATH PCI Registry.

    Sintek, Marc / Coverstone, Edward / Bach, Richard / Zajarias, Alan / Lasala, John / Kurz, Howard / Kennedy, Kevin / Singh, Jasvindar

    Circulation. Cardiovascular interventions

    2021  Volume 14, Issue 7, Page(s) e010061

    Abstract: Figure: see text]. ...

    Abstract [Figure: see text].
    MeSH term(s) Atherectomy, Coronary ; Humans ; Lasers, Excimer/adverse effects ; Percutaneous Coronary Intervention/adverse effects ; Registries
    Language English
    Publishing date 2021-06-25
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2450797-0
    ISSN 1941-7632 ; 1941-7640
    ISSN (online) 1941-7632
    ISSN 1941-7640
    DOI 10.1161/CIRCINTERVENTIONS.120.010061
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Repeat revascularisation outcomes after percutaneous coronary intervention in patients with rheumatoid arthritis.

    Sintek, Marc A / Sparrow, Christopher T / Mikuls, Ted R / Lindley, Kathryn J / Bach, Richard G / Kurz, Howard I / Novak, Eric / Singh, Jasvindar

    Heart (British Cardiac Society)

    2016  Volume 102, Issue 5, Page(s) 363–369

    Abstract: ... landmark. In the absence of RA treatments including methotrexate and/or TNFα inhibitors, RA is associated ...

    Abstract Objective: To investigate repeat revascularisation outcomes in patients with rheumatoid arthritis(RA) after percutaneous coronary intervention (PCI).
    Methods: We performed a single-centre, retrospective matched cohort study of patients with RA matched to non-RA patients post PCI. Primary endpoints were time to target lesion revascularisation (TLR) and target vessel revascularisation (TVR) analysed by Cox proportional hazard shared frailty models.
    Results: A total of 228 lesions (143 patients) were identified in the RA cohort and matched to 677 control lesions (541 patients). TLR occurred in 33% (n=75) of RA lesions versus 25% (n=166) of control lesions (adjusted HR 1.3; 95% CI 0.97 to 1.8). TVR occurred in 39% (n=89) of RA lesions versus 31% (n=213) of control lesions (adjusted HR 1.15; 95% CI 0.82 to 1.6). There was a significant hazard for TLR (adjusted HR 1.48; 95% CI 1.03 to 2.13) and TVR (adjusted HR 1.55; 95% CI 1.12 to 2.14) when excluding lesions with revascularisation events or follow-up less than 1 year. When stratified by treatment with methotrexate or tumour necrosis factor (TNF) α inhibitors or both at discharge, lesions from patients with RA treated with these agents had similar TVR and TLR as control lesions, whereas lesions from patients with RA not treated with these agents had significantly more TLR and TVR (TLR adjusted HR 1.48; 95% CI 1.08 to 2.03; TVR adjusted HR 1.38; 95% CI 1.04 to 1.84).
    Conclusions: RA predisposes to repeat revascularisation, specifically in patients followed after the 1-year landmark. In the absence of RA treatments including methotrexate and/or TNFα inhibitors, RA is associated with a 50% increased relative risk of repeat revascularisation following PCI. These findings emphasise the adverse effects of chronic inflammation on the durability of PCI and provide further support for aggressive anti-inflammatory treatment in patients with RA.
    MeSH term(s) Aged ; Antirheumatic Agents/therapeutic use ; Arthritis, Rheumatoid/complications ; Arthritis, Rheumatoid/diagnosis ; Arthritis, Rheumatoid/drug therapy ; Biological Products/therapeutic use ; Chi-Square Distribution ; Coronary Artery Disease/complications ; Coronary Artery Disease/diagnosis ; Coronary Artery Disease/therapy ; Databases, Factual ; Female ; Humans ; Immunosuppressive Agents/therapeutic use ; Kaplan-Meier Estimate ; Linear Models ; Logistic Models ; Male ; Middle Aged ; Missouri ; Multivariate Analysis ; Percutaneous Coronary Intervention/adverse effects ; Percutaneous Coronary Intervention/instrumentation ; Proportional Hazards Models ; Retreatment ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Stents ; Time Factors ; Treatment Outcome
    Chemical Substances Antirheumatic Agents ; Biological Products ; Immunosuppressive Agents
    Language English
    Publishing date 2016-03
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 1303417-0
    ISSN 1468-201X ; 1355-6037
    ISSN (online) 1468-201X
    ISSN 1355-6037
    DOI 10.1136/heartjnl-2015-308634
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Reducing Acute Kidney Injury and Costs of Percutaneous Coronary Intervention by Patient-Centered, Evidence-Based Contrast Use.

    Amin, Amit P / Crimmins-Reda, Patricia / Miller, Samantha / Rahn, Brandon / Caruso, Mary / Funk, Meghan / Pierce, Andrew / Kurz, Howard I / Lasala, John M / Zajarias, Alan / Bach, Richard G / Sintek, Marc A / Frogge, Nathan / Jain, Sudhir / Kulkarni, Hemant / Singh, Jasvindar

    Circulation. Cardiovascular quality and outcomes

    2019  Volume 12, Issue 3, Page(s) e004961

    MeSH term(s) Acute Kidney Injury/chemically induced ; Acute Kidney Injury/economics ; Acute Kidney Injury/epidemiology ; Acute Kidney Injury/prevention & control ; Aged ; Contrast Media/administration & dosage ; Contrast Media/adverse effects ; Contrast Media/economics ; Cost Savings ; Cost-Benefit Analysis ; Evidence-Based Medicine/economics ; Female ; Hospital Costs ; Humans ; Incidence ; Male ; Middle Aged ; Missouri/epidemiology ; Patient-Centered Care/economics ; Percutaneous Coronary Intervention/adverse effects ; Percutaneous Coronary Intervention/economics ; Program Evaluation ; Protective Factors ; Risk Assessment ; Risk Factors ; Time Factors
    Chemical Substances Contrast Media
    Language English
    Publishing date 2019-03-10
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2483197-9
    ISSN 1941-7705 ; 1941-7713
    ISSN (online) 1941-7705
    ISSN 1941-7713
    DOI 10.1161/CIRCOUTCOMES.118.004961
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Outcomes After the MitraClip Procedure in Patients at Very High Risk for Conventional Mitral Valve Surgery.

    Manghelli, Joshua L / Carter, Daniel I / Khiabani, Ali J / Maniar, Hersh S / Damiano, Ralph J / Sintek, Marc A / Lasala, John M / Zajarias, Alan / Melby, Spencer J

    Innovations (Philadelphia, Pa.)

    2018  Volume 13, Issue 6, Page(s) 433–437

    Abstract: Objective: Approximately 50% of patients with severe symptomatic mitral regurgitation are deemed too high risk for surgery. The MitraClip procedure is a viable option for this population. Our goal was to assess outcomes and survival of patients who ... ...

    Abstract Objective: Approximately 50% of patients with severe symptomatic mitral regurgitation are deemed too high risk for surgery. The MitraClip procedure is a viable option for this population. Our goal was to assess outcomes and survival of patients who underwent the MitraClip procedure at an institution where mitral valve surgery is routinely performed.
    Methods: A retrospective study of patients undergoing the MitraClip procedure was performed. Baseline characteristics, perioperative outcomes, and follow-up echocardiographic and clinical outcomes were examined. Primary end point was survival. Secondary end points included technical failure (residual 3/4+ mitral regurgitation), reoperation, New York Heart Association symptoms, 30-day mortality, and other clinical outcomes. Predictors of mortality were determined using multivariable regression analysis.
    Results: Fifty consecutive patients underwent the MitraClip procedure during the 4-year period. The average age was 83, the Society of Thoracic Surgeons predicted risk of mortality mean was 9.4%, 88% (44/50) had New York Heart Association III/IV symptoms, 86% (43/50) had 4+ mitral regurgitation, and 72% (36/50) had degenerative mitral disease etiology. Echocardiographic data (median [interquartile range] follow-up = 43 [26-392]) showed that 86% (43/50) of patients had 2+ or less mitral regurgitation. Sixty percent (24/40) had New York Heart Association I/II symptoms at last follow-up. Predictors of mortality were higher Society of Thoracic Surgeons predicted risk of mortality (P = 0.042, hazard ratio = 1.098) and previous cardiac surgery (P = 0.013, hazard ratio = 3.848). Survival at 1 and 2 years was 75% and 63%, respectively.
    Conclusions: Many patients with mitral valve regurgitation who are high risk for open surgery can be treated with the MitraClip procedure. In our study, most patients (86%) had a technically successful operation and postoperative outcomes including survival were acceptable.
    MeSH term(s) Aged ; Aged, 80 and over ; Cardiac Surgical Procedures/adverse effects ; Cardiac Surgical Procedures/methods ; Cardiac Surgical Procedures/mortality ; Cardiac Surgical Procedures/statistics & numerical data ; Echocardiography ; Female ; Humans ; Kaplan-Meier Estimate ; Male ; Mitral Valve/surgery ; Mitral Valve Insufficiency/mortality ; Mitral Valve Insufficiency/surgery ; Postoperative Complications ; Retrospective Studies ; Treatment Outcome
    Language English
    Publishing date 2018-12-13
    Publishing country United States
    Document type Journal Article
    ISSN 1559-0879
    ISSN (online) 1559-0879
    DOI 10.1097/IMI.0000000000000571
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: The Combination of Tricuspid Annular Plane Systolic Excursion and HeartMate Risk Score Predicts Right Ventricular Failure After Left Ventricular Assist Device Implantation.

    Raymer, David S / Moreno, Jonathan D / Sintek, Marc A / Nassif, Michael E / Sparrow, Christopher T / Adamo, Luigi / Novak, Eric L / LaRue, Shane J / Vader, Justin M

    ASAIO journal (American Society for Artificial Internal Organs : 1992)

    2018  Volume 65, Issue 3, Page(s) 247–251

    Abstract: Right ventricular (RV) failure is difficult to predict and is a major determinant of poor outcomes after left ventricular assist device (LVAD) implantation. We evaluated the associations of the following variables with severe RV failure in LVAD patients: ...

    Abstract Right ventricular (RV) failure is difficult to predict and is a major determinant of poor outcomes after left ventricular assist device (LVAD) implantation. We evaluated the associations of the following variables with severe RV failure in LVAD patients: tricuspid annular plane systolic excursion (TAPSE), pulmonary artery pulsatility index (PAPi), simplified RV contraction pressure index (sRVCPI), and HeartMate Risk Score (HMRS). We performed a retrospective case-control study on 216 patients who underwent continuous-flow LVAD implantation between 2008 and 2014. The primary analysis assessed the ability of HMRS, PAPi, sRVCPI, and TAPSE to predict severe RV failure. A secondary analysis evaluated the incremental benefit of combining predictive variables. Seventy-four patients developed severe RV failure (24%). Compared with the control group, the severe RV failure group had lower TAPSE (1.30 vs. 1.55; p < 0.001), lower PAPi (1.77 vs. 2.47; p = 0.001), lower sRVCPI (42.71 vs. 57.82; p < 0.001), and higher HMRS (2.12 vs. 1.65; p < 0.001). All four variables had similar receiver operating characteristic curves with modest area under the receiver operating characteristic curve (0.63-0.67, all p values < 0.001). In the evaluation of combined predictive variables, the combination of TAPSE with HMRS was found to be best for predicting severe RV failure. In summary, patients at risk for severe RV failure after LVAD implantation were successfully identified using TAPSE, PAPi, sRCPI, and HMRS. The combination of TAPSE and HMRS-incidentally, the least invasive and most readily available variables-proved to be superior to RV-centric metrics for predicting severe RV failure. The predictive and clinical use of these two variables should be tested prospectively.
    MeSH term(s) Adult ; Aged ; Case-Control Studies ; Female ; Heart Function Tests/methods ; Heart-Assist Devices/adverse effects ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Risk Factors ; Ventricular Dysfunction, Right/diagnosis ; Ventricular Dysfunction, Right/etiology
    Language English
    Publishing date 2018-05-03
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 759982-1
    ISSN 1538-943X ; 0162-1432 ; 1058-2916
    ISSN (online) 1538-943X
    ISSN 0162-1432 ; 1058-2916
    DOI 10.1097/MAT.0000000000000808
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Clinical and Echocardiographic Features Associated With Improved Survival in Patients With Severe Aortic Stenosis Undergoing Balloon Aortic Valvuloplasty (BAV).

    Husaini, Mustafa / Soyama, Yuko / Kagiyama, Nobuyuki / Thakker, Prashanth / Thangam, Manoj / Haque, Nowrin / Deych, Elena / Sintek, Marc / Lasala, John / Gorcsan, John / Zajarias, Alan

    The Journal of invasive cardiology

    2020  Volume 32, Issue 11, Page(s) E277–E285

    Abstract: ... Landmark analysis at 60 days showed the 47 patients who underwent TAVR/SAVR after BAV had significantly ... SAVR have markedly improved mortality, careful consideration should be given to advance definitive ...

    Abstract Background: Balloon aortic valvuloplasty (BAV) is used in high-risk patients with severe aortic stenosis (AS) when the benefit of transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement (SAVR) is unclear. Our objective was to identify clinical or echocardiographic features that identify patients likely to benefit from BAV.
    Methods: We studied 141 consecutive patients who underwent BAV from July, 2011 to October, 2017. Clinical characteristics, routine echocardiographic parameters, and speckle tracking imaging of global longitudinal strain (GLS) were assessed before and after BAV. The primary outcome was all-cause mortality as ascertained by the National Death Index.
    Results: There were 141 patients, median age, 80 years (interquartile range [IQR], 74-87 years) with severe AS (median aortic valve area, 0.66 cm²; IQR, 0.53-0.79 cm²) and median mean gradient of 36 mm Hg (IQR, 27-48 mm Hg) who underwent BAV. The 1-year mortality rate was 52%. Characteristics associated with survival were New York Heart Association class I symptoms, lower brain natriuretic peptide level, higher left ventricular ejection fraction (LVEF) >53%, and higher GLS (>13.2%; absolute values were used for GLS). Landmark analysis at 60 days showed the 47 patients who underwent TAVR/SAVR after BAV had significantly better 1-year survival than those who did not (P<.001).
    Conclusion: A high 1-year mortality rate was observed in severe AS patients selected for BAV. LVEF and left ventricular (LV)-GLS offer similar prognostic value for 1-year mortality; however, LV-GLS may have potentially increased clinical utility, as it provides a clear threshold for predicting poor outcomes compared with LVEF. As patients who undergo TAVR/SAVR have markedly improved mortality, careful consideration should be given to advance definitive valve therapy in carefully selected BAV patients.
    MeSH term(s) Aged ; Aged, 80 and over ; Aortic Valve/diagnostic imaging ; Aortic Valve/surgery ; Aortic Valve Stenosis/diagnosis ; Aortic Valve Stenosis/surgery ; Balloon Valvuloplasty ; Echocardiography ; Humans ; Retrospective Studies ; Risk Factors ; Severity of Illness Index ; Stroke Volume ; Treatment Outcome ; Ventricular Function, Left
    Language English
    Publishing date 2020-09-28
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1154372-3
    ISSN 1557-2501 ; 1042-3931
    ISSN (online) 1557-2501
    ISSN 1042-3931
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top